Mature B Cell Malignancies clinical trials

Explore recruiting mature b cell malignancies clinical trials.

Recruiting mature b cell malignancies studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mature B Cell Malignancies trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Study of BGB-11417 in Patients with Mature B Cell Malignancies

Italy, Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 1/1b Open-Label Dose-Escalation and Dose-Optimization Study of Bcl-2 Inhibitor BGB 21447 in Patients With Mature B Cell Malignancies

France, Italy

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Phase 1, open-label, multicenter, dose escalation study of SRG-1505 as monotherapy in subjects with mature b-cell malignancies

France, Poland, Romania, Italy, Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase I/II Open-Label Multi-Centre Master Protocol to Evaluate the Safety and Efficacy of AZD0486 Monotherapy or in Combination with Other Anticancer Agents in Participants with Mature B-Cell Malignancies Substudy 1: Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma Substudy 2: Mantle Cell Lymphoma Substudy 3: Large B-Cell Lymphoma

Denmark, France, Spain, Germany, Czechia

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Mature B Cell Malignancies trials by city

Mature B Cell Malignancies in Toronto Mature B Cell Malignancies in Vancouver Mature B Cell Malignancies in Montreal Mature B Cell Malignancies in Calgary Mature B Cell Malignancies in Edmonton Mature B Cell Malignancies in Ottawa Mature B Cell Malignancies in Winnipeg Mature B Cell Malignancies in Quebec City Mature B Cell Malignancies in Hamilton Mature B Cell Malignancies in Kitchener Mature B Cell Malignancies in London Mature B Cell Malignancies in Halifax Mature B Cell Malignancies in New York Mature B Cell Malignancies in Los Angeles Mature B Cell Malignancies in Chicago Mature B Cell Malignancies in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease